NDC 0006-3845-01 - INVANZ
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0006-3845
- Requested NDC
- 0006-3845-01
- Package NDCs from labels
- 0006-3845-01, 0006-3845-71
- Manufacturer
- Merck Sharp & Dohme LLC
- Effective date
- 2026-02-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| INVANZ - Merck Sharp & Dohme LLC | Merck Sharp & Dohme LLC | 2026-02-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0006-3845-01 | INVANZ | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 42 | |
| 0006-3845-71 | INVANZ | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 42 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0006-3845-01 | EA - Each | 0006-3845 | f68fa9e7-733a-4dcf-9942-af51510b014a | 1 | 2015-05-05 |
| 0006-3845-71 | EA - Each | 0006-3845 | 5ab1cc02-c4ec-4ff9-be96-58e728277102 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ERTAPENEM SODIUM | ACTIVE INGREDIENT | 2T90KE67L0 | INVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 23 | |
| ertapenem | ACTIVE MOIETY | G32F6EID2H | INVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 23 | |
| sodium bicarbonate | INACTIVE INGREDIENT | 8MDF5V39QO | INVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 23 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | INVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 23 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 88ad2e92-2228-49b2-bcee-1770fd30cb14 | 2025-12-04 | Warnings | 8MDF5V39QO |
| BM Sodium bicarbonate (Nat Bicarb) | SODIUM BICARBONATE | BM Private Limited | 38044eae-7237-6add-e063-6294a90a827b | 2025-12-02 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | bd84ca00-6352-4cb3-bce2-05f4a5005a94 | 2025-11-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Civica | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 2025-11-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Glenmark Pharmaceuticals Inc., USA | f38d0dfc-9bcc-4224-a202-885c9ad0beae | 2025-11-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Itch Eraser Sensitive | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 2250525a-45c2-42ea-e063-6394a90ac001 | 2025-11-18 | Warnings | 8MDF5V39QO |
| After Bite Kids | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 226c1420-d771-204f-e063-6294a90af9f6 | 2025-11-18 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | 8MDF5V39QO |
| After Bite X Tech | SODIUM BICARBONATE | Adventure Ready Brands | e9e49ab4-3e1f-9fd4-e053-2a95a90a775a | 2025-11-17 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2025-11-10 | Warnings | 8MDF5V39QO |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 27dbf0bf-c273-2108-e063-6394a90a0a09 | 2025-11-10 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2025-11-10 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2025-11-10 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Henry Schein, Inc. | da484a2f-154f-48b4-8467-7a86729204c3 | 2025-11-07 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea20a5eb-641e-48cd-bcfa-74c04c45dfda | 2025-11-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| CEO-TWO | LAXATIVE | Beutlich Pharmaceuticals, LLC | 08670636-5795-4db0-e063-6294a90afa4b | 2025-11-05 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.